A Nosocomial Cluster of Tigecycline- and Vancomycin-Resistant
Anti-Bacterial Agents
/ pharmacology
Cross Infection
/ microbiology
Drug Resistance, Multiple, Bacterial
/ drug effects
Enterococcus faecium
/ drug effects
Genes, Bacterial
/ genetics
Genotype
Humans
Microbial Sensitivity Tests
Tigecycline
/ pharmacology
Vancomycin
/ pharmacology
Vancomycin-Resistant Enterococci
/ drug effects
TVRE
nosocomial cluster
rpsJ
tet(M)
tigecycline resistance
Journal
Microbial drug resistance (Larchmont, N.Y.)
ISSN: 1931-8448
Titre abrégé: Microb Drug Resist
Pays: United States
ID NLM: 9508567
Informations de publication
Date de publication:
Jun 2020
Jun 2020
Historique:
pubmed:
3
1
2020
medline:
7
4
2021
entrez:
3
1
2020
Statut:
ppublish
Résumé
Tigecycline-resistant enterococci are only rarely detected worldwide. In 2017, the National Reference Centre for Staphylococci and Enterococci noticed a nosocomial cluster of tigecycline- and vancomycin-resistant
Identifiants
pubmed: 31895641
doi: 10.1089/mdr.2019.0346
doi:
Substances chimiques
Anti-Bacterial Agents
0
Vancomycin
6Q205EH1VU
Tigecycline
70JE2N95KR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM